Genetic prodrug activation therapy

Lancet

Volumn 350, Issue 9094, 1997, Pages 1793-1794

  Martin, L A ^a   Vile, R ^a   Lemoine, N R ^a   Sikora, K ^a   Pandha H S, ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRODRUG;

GENE TARGETING; GENE THERAPY; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0031588461     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)63633-1     Document Type: Note

References (8)

1. LA Martin NRL Lemoine Direct cell killing by suicide genes Cancer Metastasis Rev 15 1996 301 316
2. KW Culver Z Ram S Wallbridge H Ishii EH Oldfield RM Blaese In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors Science 256 1993 1550 1552
3. Z Ram K Culver E Oshiro Therapy of malignant brain tumours by intratumoral implantation of retroviral vector-producing cells Nat Med 3 1997 1354 1361
4. BE Huber CA Richards TA Krenitsky Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer threapy Proc Natl Acad Sci USA 88 1991 8039 8043
5. RG Vile IR Hart Use of tissue specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct injection of DNA Cancer Res 53 1993 3860 3864
6. JD Harris AA Gutierrez HC Hurst K Sikora NR Lemoine Gene therapy for cancer using tumour-specific prodrug activation Gene Ther 1 1994 170 175
7. CJA Ring P Blouin L-A Martin HC Hurst NR Lemoine Use of transcription regulatory elements from the MUG 1 and ERBB2 genes to drive tumour selective expression of a prodrug activating enzyme Gene Ther 4 1994 1045 1052
8. FL Cosset SJ Russell Targeting retrovirus entry Gene Ther 3 1996 946 956